UT Southwestern Medical Center researchers have shown that an antibody targeting endotrophin, a fat cell-derived extracellular protein, reduced growth of breast tumors in mice. The team will next study the antibody in animal models of obesity-induced cancer and test a humanized version in human cancer samples.